Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,875 | 1 | 65.3% |
| Food and Beverage | $5,776 | 183 | 25.4% |
| Travel and Lodging | $2,127 | 11 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Caerus Corp. | $14,875 | 1 | $0 (2020) |
| Boston Scientific Corporation | $1,806 | 34 | $0 (2024) |
| Stryker Corporation | $1,512 | 11 | $0 (2018) |
| Abbott Laboratories | $821.73 | 20 | $0 (2023) |
| Medical Device Business Services, Inc. | $600.87 | 2 | $0 (2018) |
| Nevro Corp. | $525.38 | 14 | $0 (2023) |
| Averitas Pharma Inc. | $520.58 | 19 | $0 (2024) |
| Curonix LLC | $364.81 | 4 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $273.86 | 18 | $0 (2024) |
| Amgen Inc. | $208.91 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $920.57 | 24 | Curonix LLC ($364.81) |
| 2023 | $1,143 | 30 | Boston Scientific Corporation ($390.67) |
| 2022 | $794.52 | 15 | Boston Scientific Corporation ($382.00) |
| 2021 | $546.72 | 21 | BOSTON SCIENTIFIC CORPORATION ($162.89) |
| 2020 | $15,008 | 8 | Caerus Corp. ($14,875) |
| 2019 | $375.13 | 24 | Nevro Corp. ($162.17) |
| 2018 | $1,711 | 33 | Medical Device Business Services, Inc. ($600.87) |
| 2017 | $2,278 | 40 | Stryker Corporation ($1,137) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $67.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $21.07 | General |
| 09/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Analgesic | ||||||
| 08/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Opioid Analgesic | ||||||
| 08/15/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Analgesic | ||||||
| 07/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $56.37 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Analgesic | ||||||
| 06/06/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $148.50 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/18/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Analgesic | ||||||
| 04/12/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/26/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/21/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/29/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $33.83 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $33.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/23/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $181.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/23/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $115.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/02/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Analgesic | ||||||
| 02/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/01/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/19/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 185 | 839 | $46,423 | $23,172 |
| 2022 | 10 | 237 | 811 | $50,592 | $27,244 |
| 2021 | 11 | 299 | 978 | $43,397 | $28,224 |
| 2020 | 6 | 228 | 286 | $25,869 | $16,456 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 81 | $12,631 | $6,906 | 54.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 33 | 54 | $7,182 | $3,728 | 51.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 14 | 17 | $6,970 | $3,487 | 50.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $6,120 | $3,255 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 49 | $5,277 | $2,904 | 55.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 18 | 18 | $5,292 | $2,769 | 52.3% |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | Office | 2023 | 15 | 70 | $350.00 | $74.03 | 21.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 520 | $2,600 | $48.22 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 85 | $12,736 | $7,459 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $8,209 | $4,977 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 71 | $7,316 | $4,479 | 61.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 30 | 49 | $6,723 | $3,424 | 50.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 15 | 16 | $5,688 | $2,897 | 50.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 18 | 18 | $5,689 | $2,851 | 50.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 11 | 11 | $1,770 | $894.17 | 50.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 11 | 11 | $372.05 | $188.59 | 50.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 21 | 456 | $1,806 | $42.08 | 2.3% |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | Office | 2022 | 15 | 52 | $283.46 | $32.70 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 73 | $9,935 | $6,415 | 64.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $7,403 | $4,850 | 65.5% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 16 | 21 | $5,135 | $3,874 | 75.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 60 | $5,920 | $3,572 | 60.3% |
| 72275 | Radiological supervision and interpretation x-ray of covering of spinal cord | Office | 2021 | 20 | 24 | $3,299 | $2,462 | 74.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 12 | 12 | $2,868 | $2,037 | 71.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 22 | 31 | $3,365 | $2,019 | 60.0% |
About Dr. Vikas Pilly, M.D
Dr. Vikas Pilly, M.D is a Pain Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841302403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikas Pilly, M.D has received a total of $22,778 in payments from pharmaceutical and medical device companies, with $920.57 received in 2024. These payments were reported across 195 transactions from 41 companies. The most common payment nature is "Consulting Fee" ($14,875).
As a Medicare-enrolled provider, Pilly has provided services to 949 Medicare beneficiaries, totaling 2,914 services with total Medicare billing of $95,096. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Williamsville, NY
- Active Since 08/31/2006
- Last Updated 03/18/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1841302403
Products in Payments
- IVS - Vertebral Augmentation Products (Device) $1,137
- WaveWriter Alpha Prime 16 (Device) $904.53
- SYNFLATE (Device) $600.87
- QUTENZA (Drug) $520.58
- SPECTRA SYSTEM (Device) $440.38
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $364.81
- Senza Spinal Cord Stimulation System (Device) $364.54
- IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) $313.51
- SPECTRA WAVEWRITER (Device) $226.50
- ZTLido (Drug) $222.87
- OCTRODE (Device) $207.48
- RS 4i Plus Sequential Stimulator (Device) $179.77
- Proclaim Family of SCS IPGs (Device) $175.70
- Senza (Device) $160.84
- AXIUM (Device) $147.49
- Varithena Administration Pack (Device) $128.53
- PENTA (Device) $127.05
- Aimovig (Biological) $108.55
- LYRICA (Drug) $106.56
- GENERAL - PAIN MANAGEMENT (Device) $106.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.